Naveen Kumar
☆    

India,
2014-06-23 15:19
(3952 d 10:19 ago)

Posting: # 13124
Views: 6,358
 

 Replicate Design [Two-Stage / GS Designs]

Dear All,

Please suggest, can we design full replicate bioequivalence study (molecule is highly variable) in stages for EMEA submission.

My concern is Power will play pivotal role in stage design, which not be in replicate (full) designs.

Regards,
Naveen Kumar.SR


Edit: Category and subject line changed. [Helmut]
ElMaestro
★★★

Denmark,
2014-06-23 15:32
(3952 d 10:06 ago)

@ Naveen Kumar
Posting: # 13125
Views: 5,229
 

 Replicate Design

Hello Naveen,

❝ Please suggest, can we design full replicate bioequivalence study (molecule is highly variable) in stages for EMEA submission.


Yes, that should be a possibility but:
  1. There are no publications about two-stage BE trials combined with replicated designs. You might be asked to prove by your own simulations that type I errors are controlled at max 5% or so.
  2. Don't do it without a meeting with FDA.

❝ My concern is Power will play pivotal role in stage design, which not be in replicate (full) designs.


Not understood - can you explain what you mean?

Pass or fail!
ElMaestro
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2014-06-23 16:53
(3952 d 08:46 ago)

@ ElMaestro
Posting: # 13128
Views: 5,298
 

 Science fiction

Hi ElMaestro & Naveen,

❝ 1. There are no publications about two-stage BE trials combined with replicated designs.


Correct.

❝ You might be asked to prove by your own simulations that type I errors are controlled at max 5% or so.


Correct again. But – unless one has access to a supercomputer or grid-computing – I would say that’s science fiction. The problem lies in the intermediate power calculation and sample size esti­ma­tion for the second stage. Contrary to 2,2,2 crossovers and parallel designs there is no explicit formula… Although the convergence is pretty fast, we still would need 105 sim’s (the 104 the two Lászlós used in their paper was too low). With Power2Stage (or your famous C-code) on a rea­son­ably fast machine 2,2,2 sim’s run for ~two days. If we add sim’s within the sim’s that would mean ~2,700 years. I don’t believe in immortality. ;-)
If you start tomorrow, ask a fortune teller for the adjusted α to validate, buy every year the latest hard­ware, and believe in Moore’s law then you’ll be done in twenty years.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Naveen Kumar
☆    

India,
2014-06-28 09:26
(3947 d 16:12 ago)

@ Helmut
Posting: # 13163
Views: 5,170
 

 Science fiction

Dear ElMaestro and Helmut,

Thank you for the suggestions, one more :confused: with out two stage in full replicate design, can i have a chance for interim analysis (EMEA).

Regards,
Naveen Kumar.SR
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2014-06-28 14:09
(3947 d 11:30 ago)

@ Naveen Kumar
Posting: # 13165
Views: 5,160
 

 Interim analysis?

Hi Naveen,

❝ […] with out two stage in full replicate design, can i have a chance for interim analysis (EMEA).


Would you please so kind and describe in simple words the purpose and performance of the interim analysis you have in mind? What decisions will you make? What measures will you take to maintain the patient’s risk?

<nitpicking>

EMEA mutated into EMA back in 2005.

</nitpicking>

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,707 registered users;
35 visitors (0 registered, 35 guests [including 9 identified bots]).
Forum time: 01:39 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5